Gentagel-Lr
GentaGel-LR was founded in late 2021 by Dr. Ariel Orbach, Mr. Eli Lerner, and Professor Abraham J. Domb. The company is based on a ground-breaking drug delivery technology invented by Prof. Domb, for the in-situ sustained release of antibiotics for the treatment and prevention of surgical site infections. GentaGel offers a local slow-release antibiotic treatment which is injected and continuously releases antibiotics (e.g, Gentamicin) for up to 60 days. The antibiotic is not detectable in circulation but achieves sufficient therapeutic concentrations in the administered area. Thus, GentaGel provides an effective antibiotic treatment while avoiding systemic side-effects and expensive cost-of-care. The Company is entering the clinical stage with a FIH Study to be conducted at the Sheba Medical Center, Israel.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
1
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Gentagel-Lr
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
Showing 1 of 1 verified contacts
Top roles at Gentagel-Lr
1 distinct titles indexed · top 1 shown.
- 1chief executive officer
Sign up to unlock all 1 contacts at Gentagel-Lr
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Gentagel-Lr
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.